Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Retention and linkage to care news

Show

From To
Researchers Report High Rate of Viral Suppression Among People New to HIV Care

Eighty-six percent of individuals who entered HIV care soon after diagnosis maintained viral suppression after 48 weeks during a clinical trial conducted at four National Institutes of Health (NIH)-funded Centers for AIDS Research (CFARs) across the United States. Participants in the clinical trial, called iENGAGE, achieved viral suppression in an average of just 63 days. The findings were presented in a poster at the Conference on Retroviruses and Opportunistic Infections (link is external) (CROI 2019) in Seattle.

Published
08 March 2019
From
NIAID
San Francisco Is Beating H.I.V. Why Can’t Houston?

We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

Published
04 March 2019
From
The New York Times
Viral load monitoring motivates HIV treatment adherence in eSwatini

The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well. 

Published
24 February 2019
From
AVERT
Viral Load Does Not Equal Value

Are We Shaming Those Who Are Detectable? To contend with this issue and fight the epidemic, we must confront structural barriers and address stigma. What’s more, we must imagine new ways to provide community support beyond offering only clinical solutions.

Published
20 February 2019
From
POZ
What stops people with HIV adhering to long term antiretroviral therapy?

Long term adherence to antiretroviral therapy (ART) is important in both reducing morbidly and mortality in people living with HIV and reducing transmission rates. A new study published in AIDS Research and Therapy explores people’s reasons for non-adherence to ART through a cohort in Uganda. They find travel, stigma, poor adherence education, and alternative medicine to be prominent factors.

Published
22 January 2019
From
BMC Blogs Network
HIV care: Karnataka bags top spot

When it comes to providing care, support and treatment to HIV patients, Karnataka has been judged the best performer among states with a high HIV burden.

Published
16 January 2019
From
Times of India
Adolescents and HIV: kindness and time key factors for treatment retention

New research from South Africa provides insights into the factors associated with retention of adolescents in HIV care, suggesting relatively low‐cost interventions could significantly improve adherence and retention in care.

Published
15 October 2018
From
AVERT
Community ART groups: bringing HIV treatment closer to patient's homes and to communities in conflict

Charles Ssonko of Médecins sans Frontières describes the role of community groups in maintaining access to antiretroviral drugs for patients in Central African Republic, even under the most difficult and dangerous circumstances.

Published
03 October 2018
From
PLoS Blogs
Social Determinants of Health Debated at USCA 2018

To enroll and retain people with HIV in treatment, physicians and HIV care providers need to acknowledge the social determinants of health and the barriers that keep patients, especially young people of color, out of care.

Published
04 September 2018
From
Medscape (requires free registration)
Zambia: Patients With HIV Will Forgo Short Wait Time, Travel Distance to Access Nice Providers

Patients with HIV indicated a strong preference for “nice” over “rude” providers and a willingness to wait 19 hours more or travel 28 miles farther to see nice rather than rude providers.

Published
03 September 2018
From
American Journal of Managed Care

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.